Not exactly. Even though equally target GLP-1 receptors, Tirz also activates GIP receptors, which makes it a dual agonist. This broader system is considered to boost its consequences on insulin sensitivity and urge for food signaling in investigate types. Moreover, early-stage investigation implies achievable protecting results on pancreatic islet framework https://peptisell.com/product/nad-plus